Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal hydromorphone for postoperative analgesia in benign anorectal surgery
ChiCTR2500100994Phase 4Not yet recruiting
- Sponsor
- Deyang People's Hospital
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydromorphone in Anorectal disease, hemorrhoid, anal fissure and 3 more (2 arms), sponsored by Deyang People's Hospital. Primary endpoints: Duration of postoperative analgesia and Pain score. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
hydromorphone
03
Conditions
Anorectal diseasehemorrhoidanal fissureanal fistulaperianal abscess
Beyond the preview
Go deeper on ChiCTR2500100994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100994.